name:-0.035432815551758
name:-0.036545991897583
name:-0.0048189163208008
Active Biotech AB Patent Filings

Active Biotech AB

Patent Applications and Registrations

Patent applications and USPTO patent grants for Active Biotech AB.The latest application filed is for "treatment of ocular inflammatory diseases using laquinimod".

Company Profile
6.41.38
  • Active Biotech AB - Lund DE
  • Active Biotech AB -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Treatment Of Ocular Inflammatory Diseases Using Laquinimod
App 20210386731 - Kaye; Joel ;   et al.
2021-12-16
Compounds for Treatment of Eye Diseases Associated With Excessive Vascularisation
App 20210322400 - Eriksson; Helena ;   et al.
2021-10-21
Combination Of Tasquinimod Or A Pharmaceutically Acceptable Salt Thereof And A Pd-1 And/or Pd-l1 Inhibitor, For Use As A Medicam
App 20200129499 - SOARES; Jose Amauri ;   et al.
2020-04-30
Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors
Grant 10,385,069 - Wellmar , et al. A
2019-08-20
Quinoline carboxamides for use in the treatment of multiple myeloma
Grant 10,314,836 - Liberg , et al.
2019-06-11
Quinoline carboxamides for use in the treatment of leukemia
Grant 10,300,053 - Eriksson , et al.
2019-05-28
N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors
Grant 10,125,125 - Fritzson , et al. November 13, 2
2018-11-13
Imidazo[2,1-b]thiazole And 5,6-dihydroimidazo[2,1-b]thiazole Derivatives Useful As S100-inhibitors
App 20180282348 - WELLMAR; Ulf ;   et al.
2018-10-04
Quinoline Carboxamides For Use In The Treatment Of Multiple Myeloma
App 20180228794 - LIBERG; David ;   et al.
2018-08-16
N-(heteroaryl)-sulfonamide Derivatives Useful As S100-inhibitors
App 20180155330 - FRITZSON; Ingela ;   et al.
2018-06-07
Quinoline carboxamides for use in the treatment of multiple myeloma
Grant 9,956,212 - Liberg , et al. May 1, 2
2018-05-01
N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors
Grant 9,873,687 - Fritzson , et al. January 23, 2
2018-01-23
Quinoline Carboxamides For Use In The Treatment Of Leukemia
App 20170319568 - ERIKSSON; Helena ;   et al.
2017-11-09
Quinoline Carboxamides For Use In The Treatment Of Multiple Myeloma
App 20170273967 - LIBERG; David ;   et al.
2017-09-28
Compounds useful as S100-inhibitors
Grant 9,771,372 - Wellmar , et al. September 26, 2
2017-09-26
Novel Compounds Useful As S100-inhibitors
App 20170204098 - WELLMAR; Ulf ;   et al.
2017-07-20
N-(heteroaryl)-sulfonamide Derivatives Useful As S100-inhibitors
App 20160115158 - FRITZSON; Ingela ;   et al.
2016-04-28
Deuterium-enriched 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[(4-trifluoro-methyl)phenyl]-1,2- -dihydroquinoline-3-carboxamide
Grant 9,216,956 - Svensson December 22, 2
2015-12-22
Method for manufacturing of quinoline-3-carboxamides
Grant 8,871,936 - Bock , et al. October 28, 2
2014-10-28
S100A9 interaction screening method
Grant 8,841,421 - Bjork , et al. September 23, 2
2014-09-23
Crystalline salts of quinoline compounds and methods for preparing them
Grant 8,754,104 - Jansson , et al. June 17, 2
2014-06-17
Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2- -dihydroquinoline-3-carboxamide
App 20140112946 - Svensson; Leif
2014-04-24
Stable laquinimod preparations
Grant 8,545,885 - Safadi , et al. October 1, 2
2013-10-01
Crystalline Salts Of Quinoline Compounds And Methods For Preparing Them
App 20130123301 - JANSSON; Karl ;   et al.
2013-05-16
Method For Manufacturing Of Quinoline-3-carboxamides
App 20130109860 - Bock; Lillemor Maria ;   et al.
2013-05-02
Crystalline salts of quinoline compounds and methods for preparing them
Grant 8,314,124 - Jansson , et al. November 20, 2
2012-11-20
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
Grant 8,293,243 - Hedlund , et al. October 23, 2
2012-10-23
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
Grant 7,763,253 - Hedlund , et al. July 27, 2
2010-07-27
S100a9 Interaction Screening Method
App 20100166775 - Bjork; Per ;   et al.
2010-07-01
Conjugates Between A Variant Staphylococcal Enterotoxin E Superantigen And A Targeting Antibody That Binds To A Cancer-associated Cell Surface Structure
App 20100111978 - FORSBERG; GORAN ;   et al.
2010-05-06
Tetracyclic immunomodulatory compounds
Grant 7,674,906 - Matthews , et al. March 9, 2
2010-03-09
Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen
Grant 7,615,225 - Forsberg , et al. November 10, 2
2009-11-10
Crystalline Salts Of Quinoline Compounds And Methods For Preparing Them
App 20090232889 - Jansson; Karl ;   et al.
2009-09-17
Compositions containing quinoline compounds
Grant 7,589,208 - Jansson , et al. September 15, 2
2009-09-15
Compounds
Grant 7,553,849 - Bjork , et al. June 30, 2
2009-06-30
Antibody with specificity for colon cancer
Grant 7,425,623 - Brodin , et al. September 16, 2
2008-09-16
Novel Benzofurans and Indols
App 20080119485 - WELLNER; Eric ;   et al.
2008-05-22
Benzofurans and indols
Grant 7,339,059 - Wellner , et al. March 4, 2
2008-03-04
Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
Grant 7,226,601 - Abrahmsen , et al. June 5, 2
2007-06-05
Novel compounds
App 20070112179 - Brodin; Thomas ;   et al.
2007-05-17
Novel engineered superantigen for human therapy
App 20070082001 - Forsberg; Goran ;   et al.
2007-04-12
Compounds
Grant 7,189,816 - Brodin , et al. March 13, 2
2007-03-13
Engineered superantigen for human therapy
Grant 7,125,554 - Forsberg , et al. October 24, 2
2006-10-24
Immunomodulatory compounds
App 20060217411 - Matthews; Ian Richard ;   et al.
2006-09-28
Immunomodulatory compounds
Grant 7,081,456 - Matthews , et al. July 25, 2
2006-07-25
Compounds, methods for their preparation and use thereof
Grant 7,074,831 - Jonsson , et al. July 11, 2
2006-07-11
Novel compounds
App 20060004038 - Bjork; Anders ;   et al.
2006-01-05
Cytolysis of target cells by superantigen conjugates inducing T-cell activation
App 20050226885 - Soegaard, Morten ;   et al.
2005-10-13
Process for the manufacture of quinoline derivatives
App 20050215586 - Jansson, Karl
2005-09-29
Immunomodulatory compounds
App 20050203118 - Matthews, Ian Richard ;   et al.
2005-09-15
New compositions containing quinoline compounds
App 20050192315 - Jansson, Karl ;   et al.
2005-09-01
Novel cinnamic amides
App 20050192289 - Wellner, Eric ;   et al.
2005-09-01
Novel benzofurans and indols
App 20050192288 - Wellner, Eric ;   et al.
2005-09-01
New compounds, methods for their preparation and use thereof
App 20050187297 - Jonsson, Stig ;   et al.
2005-08-25
Process for the manufacture of quinoline derivatives
Grant 6,875,869 - Jansson April 5, 2
2005-04-05
Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cells
App 20040146531 - Antonsson, Per ;   et al.
2004-07-29
Immunomodulatory compounds
App 20040116461 - Matthews, Ian Richard ;   et al.
2004-06-17
Identification of target structures E.G. in vivo selection method for a phage library
Grant 6,727,062 - Brodin , et al. April 27, 2
2004-04-27
Process for the manufacture of quinoline derivatives
App 20040034227 - Jansson, Karl
2004-02-19
Immunomodulating compounds
Grant 6,642,249 - Bjork , et al. November 4, 2
2003-11-04
Quinoline derivatives
Grant 6,605,616 - Bjork , et al. August 12, 2
2003-08-12
Quinoline derivatives
Grant 6,593,343 - Bjork , et al. July 15, 2
2003-07-15
Quinoline derivatives
App 20020173520 - Bjork, Anders ;   et al.
2002-11-21
Quinoline derivatives
App 20020173519 - Bjork, Anders ;   et al.
2002-11-21
Drugs for the treatment of malignant tumors
Grant 6,395,750 - Hedlund , et al. May 28, 2
2002-05-28
Quinoline derivatives
Grant 6,077,851 - Bjork , et al. June 20, 2
2000-06-20
Company Registrations
SEC0001573865Active Biotech AB/ADR

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed